Oligonucleotide Therapeutics Society
@OTSociety
Followers
4K
Following
2K
Statuses
8K
A nonprofit forum to foster academia and industry based research and development of oligonucleotide therapeutics.
San Diego, CA
Joined July 2013
The OTS Job Board is your one-stop solution for finding top talent. Post jobs and reach a wide audience of qualified candidates. Easily review resumes and manage applications. Visit the OTS website to learn more.
0
0
2
Fuel your curiosity! Uncover groundbreaking research and intriguing insights in our "Science News" section. These articles are available on the OTS website anytime for your convenience. Access that insight here: #OTS #oligotherapeutics #oligonucleotides
0
0
0
THIS WEEK! Join our webinar on Thursday, February 13th, from 11 am-12 pm EST, where we will hear from Trisha Das, Edwin van Oosten, and Josh Robinson, Poster Winners from OTS24. Learn more and register TODAY! #ots #oligotherapeutics #oligonucleotide
0
3
7
The OTS Education Committee would like to remind you that Oligonucleotide Safety Working Group (OSWG) White Papers are available on the OTS website for reference. View them at: #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology #whitepapers
0
0
0
FCS is a genetic disorder that leads to extremely high levels of triglycerides in the blood and poses significant health risks, including recurrent episodes of acute pancreatitis. #ots #oligotherapeutics #oligonucleotide #FCS #geneticdisorders
0
0
1
It's not too late to register for the First Nucleic Acid Therapeutics Regional Meeting in Bengaluru, India! Join us February 18-21, 2025. Register to attend and learn more here: #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology #science
0
1
3
The regional and local delivery grant applications are due soon! The applications are accepted on a rolling basis and are reviewed twice a year, with the next review on March 15, 2025. Apply today: #ots #oligotherapeutics #oligonucleotide #biotech
0
1
1
Join us for our Poster Winners #OTS24 Session 2 webinar on Thursday, February 13th from 11 am-12 pm EST! We will be hearing from Trisha Das, Edwin van Oosten, and Josh Robinson. Register NOW: #ots #oligotherapeutics #oligonucleotide #biotech
0
1
3
RT @ShihchengGuo: A novel #siRNA scaffold enables potent dual-targeting of two genes in the CNS, offering hope for complex #neurodegenerati…
0
2
0
Your Next Career Move is Here! Are you looking for a role in oligonucleotide therapeutics? OTS has a variety of positions to suit your skills and experience. See what employers have posted here: #ots #oligotherapeutics #oligonucleotide #biotech
0
0
1
Experience the Power of the OTS Member Community. - Network with Renowned Oligonucleotide Researchers - Drive Innovation Through Strategic Partnerships - Access Exclusive Resources and Opportunities Become an OTS member today: #ots #oligotherapeutics
0
1
2
Do you want to gain insight into the OTS President’s perspective? Read a recently chosen article that explores the transformative potential of RNA-based therapies. Read more of the President’s pick here: #ots #oligotherapeutics #oligonucleotide #biotech
0
1
2
RT @ShihchengGuo: Endothelial IGFBP6 curbs vascular inflammation and atherosclerosis. IGFBP6↓ in human atherosclerotic arteries & sera. SiR…
0
1
0
RT @ShihchengGuo: Evaluated BRCA2 variants (exons 15-26) to aid cancer risk assessment. Functional insights enhance variant classification,…
0
1
0
RT @ShihchengGuo: CRISPR/Cas9 edits >90% of CCR5 in human stem cells, shielding xenograft mice from HIV. Potential alternative to rare, ris…
0
1
0
RT @ShihchengGuo: CRISPR spacer acquisition in the human gut is rare, with 1 spacer/∼2.9 mutations or ∼2.7 years. Discoveries show a preval…
0
1
0
RT @ShihchengGuo: Explore CRISPRoffT, a new database for pinpointing CRISPR/Cas off-targets, crucial for refining gene-editing therapies. D…
0
1
0